Connexios Life Sciences, Boehringer Ingelheim in pact
Boehringer Ingelheim obtains global rights to CNX-012, Connexios Life Sciences’ programme on AMPK activators
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India remains on USTR Priority Watch List
US trade body announces more in-depth investigation into India's patent laws
Merck receives final antitrust clearance for AZ takeover
Merck has received Chinese antitrust clearance from the Ministry of Commerce of the People’s Republic of China (MOFCOM), meaning…
Glenmark gets BSE nod to merge subsidiaries with itself
It has received nod for the merger of Glenmark Generics and Glenmark Access
Jubilant Biosys collaborates with Orion Corporation
The research deal is aimed at developing drug that can benefit large population of people with unmet needs in the pain management…
Hilleman Laboratories’ technology to help improve routine immunisation in India
Thermostability technology will act as a catalyst in bridging the gap between academia and product development
Abbott bags award for operational excellence
Clonmel, Ireland, facility is the first site in Europe to receive the prestigious Shingo Prize
Cabinet clears KKR’s proposal to acquire stakes in two pharma companies
The two deals are estimated to be worth Rs 1,434 crores
Novartis granted injunctions against four other generic makers over Galvus
Novartis filed an RTI with the DCGI seeking information regarding regulatory approvals issued for Vildagliptin